Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Antiarthritic agents with good safety reported by Toyama

Nov. 8, 1996

Zenapax enters clinical trials for uveitis

Nov. 1, 1996

Prolonged treatment with Salagen Tablets not associated with tachyphylaxis

Nov. 1, 1996

PDL signs agreement with Roche for humanized antibody

Nov. 1, 1996

Collagenase inhibitor from Roche for arthritic conditions

Nov. 1, 1996

Antiarthritic agents reported by Kaken

Nov. 1, 1996

ADIR investigates COX-2 inhibitors

Nov. 1, 1996

Key lupus patent issued to Genelabs

Oct. 25, 1996

AM-425 available for licensing

Oct. 25, 1996

PRIMATIZED monoclonal antibody proven safe and effective for rheumatoid arthritis

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...